Everstone acquires controlling stake in Softgel Healthcare
Veda Corporate Advisors was the exclusive financial advisor to SHPL and its shareholders.
Veda Corporate Advisors was the exclusive financial advisor to SHPL and its shareholders.
The capital expansion program commenced in June 2022 and is expected to complete in 2024
The Board also decided that Auro Vaccines will explore the possibilities of offering contract manufacturing to global vaccine developers
The MOU provides for assistance in the form of efficient working Capital Management, development and commercialisation of new products, logistic supply chain management support etc.
Sandoz is planned to be incorporated in Switzerland and to be listed on the SIX Swiss Exchange, with an American Depositary Receipt (ADR) program in the US
The company shall be engaged in the business of manufacturing of pharmaceutical, bio-pharmaceutical and biological products of any kind
The funding round also saw participation from some of India's top angel investors and leading industry giants
The hospital is being constructed at an estimated cost of around Rs. 6,000 crore and will provide healthcare facilities to the people of Faridabad and the entire NCR region
Pharmaceutical sales de-grew 18% YoY and stood at Rs. 224 crore whereas Crop Protection sales de-grew by 15% at Rs. 154 crore
Subscribe To Our Newsletter & Stay Updated